Atıf İçin Kopyala
Yalcin A. D., ÇİLLİ A., Bisgin A., Strauss L. G., Herth F.
EXPERT OPINION ON BIOLOGICAL THERAPY, cilt.13, sa.9, ss.1335-1341, 2013 (SCI-Expanded)
Background: There have been concerns about the cardiovascular safety of omalizumab.